The World Health Organization (WHO) estimates that 10.4 million persons developed tuberculosis (TB) worldwide in 2016, corresponding to a global incidence of 140 TB cases per 100 000
population. Of those who developed TB, 1.0 million cases (10%) occurred among persons living with HIV. The worldwide ...
The purpose of WHO’s Global Tuberculosis Report is to provide a comprehensive and up-to-date assessment of the TB epidemic and of progress in care and prevention at global, regional and country levels. This is done in the context of recommended global TB strategies and associated ...
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туберкулеза, в том числе новым и применяющимся по новым показаниям. Мы приводим подробные сведения о расценках на препараты для лечения лекарственно-устойчивого туберкулеза, полученные от производителей, а также ...
This document summarises the main outcomes of the Guidelines Development Group (GDG) meeting held in Geneva, Switzerland, from 9 to 11 November 2015 to advise the World Health Organization Global TB Programme (WHO/GTB) on the revision of the policies on drug-resistant tuberculosis treatment. This 2016 ...
The Tenth Meeting of the European Technical Advisory Group on Tuberculosis Control was held in Copenhagen on 9–10 November 2015. The objectives of the meeting were to:
(i) review the epidemiology of TB and drug-resistant TB in the WHO European Region, including the burdens and trends;
(ii) ...
Resistance to tuberculosis (TB) drugs is a formidable obstacle to effective TB care and prevention globally. Multidrug-resistant TB (MDR-TB) is multifactorial and fuelled by improper treatment of patients, poor management of supply and quality of drugs, and airborne transmission of bacteria in public places. Case ...
Потребители инъекционных наркотиков (ПИН) подвержены повышенному риску инфицирования и развития туберкулеза (ТБ), независимо от их ВИЧ-статуса; ТБ является одной из ведущих причин ВИЧ-ассоциированной смертности среди ПИН. ПИН также существенно чаще инфицируются ВИЧ, гепатитом В и гепатитом С.
Профилактика, диагностика и лечение ТБ, ВИЧ и вирусного гепатита ...
People who inject drugs (PWID) are at increased risk of tuberculosis (TB). HIV further increases the risk of developing TB, with TB being a leading cause of mortality among PWID who live with HIV. Much of the evidence relates to TB among PWID; however, people ...
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
